Literature DB >> 10666389

Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas.

S Schölzel1, W Zimmermann, G Schwarzkopf, F Grunert, B Rogaczewski, J Thompson.   

Abstract

Four members of the carcinoembryonic antigen (CEA) family, CEA, CEACAM1 (BGP), CEACAM6 (NCA-50/90), and CEACAM7 (CGM2), are coexpressed in normal colorectal epithelia but are deregulated in colorectal cancers, where they could play a role in tumorigenesis. As a basis for functional studies, their expression patterns in normal tissues first need to be clarified. This is well documented for CEACAM1 and CEA but not for CEACAM6 or CEACAM7. We have now carried out immunohistochemical expression studies on 35 different organs, using CEACAM6-specific (9A6) and CEACAM7-specific (BAC2) monoclonal antibodies. CEACAM7 was only found on the apical surface of highly differentiated epithelial cells in the colorectal mucosa and on isolated ductal epithelial cells within the pancreas. CEACAM6 was expressed in granulocytes and epithelia from various organs. CEACAM6 and CEACAM7 expression correlated with apoptosis at the table region of the normal colon, and both were absent from highly proliferating cells at the base of colonic crypts. CEACAM6 revealed a broader expression zone in proliferating cells in hyperplastic polyps and adenomas compared with normal mucosa, whereas CEACAM7 was completely absent. Down-regulation of CEACAM7 and up-regulation of CEACAM6 expression in hyperplastic polyps and early adenomas represent some of the earliest observable molecular events leading to colorectal tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10666389      PMCID: PMC1850034          DOI: 10.1016/S0002-9440(10)64764-5

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

1.  Down-regulation of carcinoembryonic antigen family member 2 expression is an early event in colorectal tumorigenesis.

Authors:  J Thompson; M Seitz; E Chastre; M Ditter; C Aldrian; C Gespach; W Zimmermann
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

Review 2.  Multichain immune recognition receptors: similarities in structure and signaling pathways.

Authors:  A D Keegan; W E Paul
Journal:  Immunol Today       Date:  1992-02

3.  CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.

Authors:  J Sträter; I Wellisch; S Riedl; H Walczak; K Koretz; A Tandara; P H Krammer; P Möller
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

4.  Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells.

Authors:  N Beauchemin; T Kunath; J Robitaille; B Chow; C Turbide; E Daniels; A Veillette
Journal:  Oncogene       Date:  1997-02-20       Impact factor: 9.867

5.  Expression of CD66a (human C-CAM) and other members of the carcinoembryonic antigen gene family of adhesion molecules in human colorectal adenomas.

Authors:  P Nollau; H Scheller; M Kona-Horstmann; S Rohde; F Hagenmüller; C Wagener; M Neumaier
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

6.  Proliferation and apoptosis in proliferative lesions of the colon and rectum.

Authors:  Y Kikuchi; W N Dinjens; F T Bosman
Journal:  Virchows Arch       Date:  1997-08       Impact factor: 4.064

7.  Differential recognition of members of the carcinoembryonic antigen family by Opa variants of Neisseria gonorrhoeae.

Authors:  M P Bos; F Grunert; R J Belland
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Hair cycle-dependent expression of a nonspecific cross reacting antigen (NCA)-50/90-like molecule on follicular keratinocytes.

Authors:  Y Honda; K Egawa; M Kuroki; T Ono
Journal:  Arch Dermatol Res       Date:  1997-07       Impact factor: 3.017

9.  Predominant expression of mRNA coding for nonspecific cross-reacting antigen in colorectal carcinomas.

Authors:  K F Chi; J M Jessup; M L Frazier
Journal:  Tumour Biol       Date:  1991

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  72 in total

1.  CEA family gene expression and Ki67 staining in hyperplastic polyps versus in tubular adenomas.

Authors:  B Ruebner; R Saroufeem; B Minutes; H Tesluk; M Lawson
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

2.  Proximal versus distal hyperplastic polyps of the colorectum: different lesions or a biological spectrum?

Authors:  K Baker; Y Zhang; C Jin; J R Jass
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

3.  Diverse oligomeric states of CEACAM IgV domains.

Authors:  Daniel A Bonsor; Sebastian Günther; Robert Beadenkopf; Dorothy Beckett; Eric J Sundberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

4.  G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.

Authors:  Francesco Casciello; Fares Al-Ejeh; Greg Kelly; Donal J Brennan; Shin Foong Ngiow; Arabella Young; Thomas Stoll; Karolina Windloch; Michelle M Hill; Mark J Smyth; Frank Gannon; Jason S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-19       Impact factor: 11.205

5.  Carcinoembryonic antigen-related cell adhesion molecule 10 expressed specifically early in pregnancy in the decidua is dispensable for normal murine development.

Authors:  Daniela Finkenzeller; Beate Fischer; Sabine Lutz; Heinrich Schrewe; Takehiko Shimizu; Wolfgang Zimmermann
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions.

Authors:  Mark S Duxbury; Evan Matros; Thomas Clancy; Gerald Bailey; Michael Doff; Michael J Zinner; Stanley W Ashley; Anirban Maitra; Mark Redston; Edward E Whang
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

7.  Downregulation of CEACAM6 gene expression in laryngeal squamous cell carcinoma is an effect of DNA hypermethylation and correlates with disease progression.

Authors:  Kinga Bednarek; Magdalena Kostrzewska-Poczekaj; Marcin Szaumkessel; Katarzyna Kiwerska; Julia Paczkowska; Ewa Byzia; Adam Ustaszewski; Joanna Janiszewska; Anna Bartochowska; Reidar Grenman; Malgorzata Wierzbicka; Krzysztof Szyfter; Maciej Giefing; Malgorzata Jarmuz-Szymczak
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

8.  Systemic siRNA-mediated gene silencing: a new approach to targeted therapy of cancer.

Authors:  Mark S Duxbury; Evan Matros; Hiromichi Ito; Michael J Zinner; Stanley W Ashley; Edward E Whang
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

Review 9.  Therapeutic antibodies for the treatment of pancreatic cancer.

Authors:  Patrick Chames; Brigitte Kerfelec; Daniel Baty
Journal:  ScientificWorldJournal       Date:  2010-06-15

10.  Neisserial Opa Protein-CEACAM Interactions: Competition for Receptors as a Means of Bacterial Invasion and Pathogenesis.

Authors:  Jennifer N Martin; Louise M Ball; Tsega L Solomon; Alison H Dewald; Alison K Criss; Linda Columbus
Journal:  Biochemistry       Date:  2016-08-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.